Announcement of Hubei Jumpcan Pharmaceutical Co., Ltd. regarding the adjustment of the maximum repurchase price after the implementation of the annual equity distribution in 2023.

SZSI · Jun 11

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.